Anti-atherosclerosis role of N-oleoylethanolamine in CB2

Yaoxue Xuebao

Volumn 49, Issue 3, 2014, Pages 316-321

  Gai, Ya Ting ^a,c   Shu, Qiang ^b   Chen, Cai Xia ^a,c   Lai, You Lin ^a   Li, Wen Jun ^a   Peng, Lu ^a   Lin, Li Min ^a   Jin, Xin ^a,c  

^a XIAMEN UNIVERSITY   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

^c Xiamen Key Laboratory of Chiral Drugs   (China)

Author keywords

Inflammation; N oleoylethanolamine

Indexed keywords

6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; CANNABINOID 2 RECEPTOR; MESSENGER RNA; N OLEOYLETHANOLAMINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; 3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ANTIINFLAMMATORY AGENT; ENDOCANNABINOID; ETHANOLAMINE DERIVATIVE; INDOLE DERIVATIVE; IODOPRAVADOLINE; N-OLEOYLETHANOLAMINE; OLEIC ACID;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; DRUG ACTIVITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; CELL ADHESION; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; ENDOTHELIUM CELL; GENETICS; METABOLISM; MONOCYTE; PATHOLOGY;

ANTI-INFLAMMATORY AGENTS; ATHEROSCLEROSIS; CELL ADHESION; CELLS, CULTURED; ENDOCANNABINOIDS; ENDOTHELIAL CELLS; ETHANOLAMINES; HUMANS; INDOLES; MONOCYTES; OLEIC ACIDS; PPAR ALPHA; RECEPTOR, CANNABINOID, CB2; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84900522434     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Ross R. Atherosclerosis - an inflammatory disease [J]. N Engl J Med, 1999, 340: 115-126. (Pubitemid 29054847)
2. Zhao JJ, Zhao LF, Yang H, et al. Effects of PPAR-alpha activation on oleic acid-induced steatosis and expression of heme oxygenase-1 in HepG2 cells [J]. Chin J Hepatol, 2013, 21: 218-221.
3. Lee HJ, Choi SS, Park MK, et al. Fenofibrate lowers abdominal and skeletal adiposity and improves insulin sensitivity in OLETF rats [J]. Biochem Biophys Res Commun, 2002, 296: 293-299.
4. Attridge RL, Frei CR, Ryan L, et al. Fenofibrate-associated nephrotoxicity: a review of current evidence [J]. Am J Health Syst Pharm, 2013, 70: 1219-1225.
5. Pettersen JC, Pruimboom-Brees I, Francone OL, et al. The PPARα agonists fenofibrate and CP-778875 cause increased β-oxidation, leading to oxidative injury in skeletal and cardiac muscle in the rat [J]. Toxicol Pathol, 2012, 40: 435-447.
6. Qin W, Jin X, Chen CX, et al. Effect of oleoylethanolamide on expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells [J]. Chin J Biochem Pharm, 2008, 29: 374-377.
7. Fu J, Gaetani S, Oveisi F, et al. Oleoylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha [J]. Nature, 2003, 425: 90-93. (Pubitemid 37101723)
8. Montecucco F, Di Marzo V, da Silva RF, et al. The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques [J]. Eur Heart J, 2012, 33: 846-856.
9. 2-receptor stimulation attenuates TNFα-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion [J]. Am J Physiol Heart Circ Physiol, 2007, 293: 2210-2218.
10. Xu Y, Zi ZQ, Su QH, et al. The cultivation and identification of HUVEC [J]. J Tianjin Med Univ 2000, 6: 373-375.
11. Wu JY, Zhang L, Zhang XY, et al. Cultivation and identification of endothelial cells in vitro from human umbilical vein [J]. Chin J Lab Diagn, 2010, 14: 511-513.
12. Zandbergen F, Plutzky J. PPARα in atherosclerosis and inflammation [J]. Biochim Biophys Acta, 2007, 1771: 972-982.
13. 2 cannabinoid receptor agonists attenuate TNFα induced human vascular smooth muscle cell proliferation and migration [J]. Br J Pharmacol, 2008, 153: 347-357.
14. Pacher P, Mechoulam R. Is lipid signaling through cannabinoid 2 receptors part of a protective system? [J]. Prog Lipid Res, 2011, 50: 193-211.
15. Witztum JL, Lichtman AH. The influence of innate and adaptive immune responses on atherosclerosis [J]. Annu Rev Pathol, 2014, 9: 73-102.
16. 2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury [J]. Br J Pharmacol, 2012, 165: 2462-2478.
17. 2, regulates bone mass [J]. Proc Natl Acad Sci USA, 2006, 103: 696-701.
18. Paulsen K, Tauber S, Timm J, et al. The cannabinoid receptors agonist WIN55212-2 inhibits macrophageal differentiation and alters expression and phosphorylation of cell cycle control proteins [J]. Cell Commun Signal, 2011, 9: 33.